CopyMark Law Group
4.9/5
Drawing for KETICAP

USPTO serial 79381069

KETICAP

Reviewed by CopyMark Law Group

Reg. 7674096Status 700Registered
Filing date
Status date
Registration date
Feb 4, 2025
Examiner
KAPLAN, VALERIE ELIZABETH
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with KETICAP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

MICHELLE A. COOKE

MICHELLE A. COOKE ARENTFOX SCHIFF LLP555 South Flower Street, 43rd FloorLOS ANGELES, CA 90071United States

Goods and services

ClassDescriptionStatusFirst use
005Adhesive compositions for medical use, namely, adhesive tapes for medical purposes; self-adhesive dressing strips; self-adhesive dressings; adhesive films for medical use; adhesive patches for medical purposes; adhesive plaster for medical purposes; adhesive skin patches for medical use; adhesive strips for medical purposes for closing wounds or incisions; adhesive tapes for medical purposes; anaesthetic preparations; anaesthetics; analgesic preparations; analgesics; capsules for medicines, namely capsules sold empty for pharmaceuticals; capsules, sold empty for pharmaceutical purposes; chemical pessaries for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; chemical preparations for medical purposes; chemical preparations for pharmaceutical purposes, namely, for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; pharmaceutical compounds for treating cancer; dermatological pharmaceutical substances; dressings, medical; medicinal drinks; drugs for medical purposes namely, pharmaceutical preparations for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; filled syringes for medical purposes containing pharmaceuticals for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation gauze compresses; hand creams for medical use for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; medicated hand lotion; impregnated medicated pads; medicinal infusions for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; Ammonia inhalants; skin lotions for pharmaceutical purposes; tissues impregnated with pharmaceutical skin lotions; medicated mouth spray in the nature of a mouthwash; medicated mouthwash; medicated plasters; medicinal creams for skin care; medicinal creams for the protection of the skin; medicinal drinks; medicinal ointments, namely, medicated skin lotions; medicines for human purposes, namely pharmaceutical preparations for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; medicines for veterinary purposes, namely pharmaceutical preparations for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; pharmaceutical moisturising body lotion; pharmaceutical moisturising creams; medicated anti- cavity mouth rinses for medical use; mouth sprays for medical use in the nature of medicinal preparations for the mouth and as sprays; mouthwashes for medical purposes; medicated night creams; pads impregnated with medicated preparation for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; medicated pain relief medication; pain relieving creams; pharmaceutical and veterinary preparations for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; pharmaceutical compositions for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; pharmaceutical creams for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; pharmaceutical implants, namely, implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; pharmaceutical preparations for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; pharmaceutical preparations for animal skincare; pharmaceutical preparations for animals for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; pharmaceutical preparations for skin care; pharmaceutical preparations for veterinary use for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; pharmaceutical skin lotions; pharmaceutical sweets for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; surgical plasters; medical plasters; plasters for medical purposes; pharmaceutical skin care creams for medical use; medicated skin care lotions; pharmaceutical preparations for skin care; skin patches for the transdermal delivery of pharmaceuticals for use in the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; medicated skin tonics in the nature of pharmaceutical skin care serums; medicated therapeutic creams for the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; topical analgesic creams; transdermal patches for use in the treatment and promotion of mental health and wellness, and for the treatment and prevention of mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammationACTIVE—
042Basic and clinical research in the field of respiratory science and medicine; behavioural analysis of chemicals in the nature of chemical analysis; biochemical research; biochemical research and development; biochemistry research services; biochemistry services, namely biochemical research and analysis; biological research, clinical research and medical research in the field of mental health and wellness, mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation biomedical research services; biotechnological research; biotechnological research relating to industry; biotechnology research; chemical research; clinical research in the field of mental health and wellness, mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; Providing medical and scientific research information in the field of clinical trials; Medical and scientific research, namely, conducting clinical trials for others; medical research, namely, conducting clinical trials for others; conducting early evaluations in the field of new pharmaceuticals; conducting of technical feasibility studies in the field of new technologies; design of products, namely new product design services; research and development of products in the nature of new product design services; medical laboratory research services; laboratory research services relating to pharmaceuticals; laboratory services, namely laboratory research in the field of pharmaceuticals; new products design services; testing of new products for others; technical writing, namely, preparation of reports relating to technical research; technical writing, namely, preparation of scientific reports; technical writing, namely, preparation of technical manuals; technical writing, namely, preparation of technical reports; technical writing, namely, preparation of technical studies; technical writing, namely, preparation of technological reports; product failure analysis services; new product design and development; product development; product research; product research and development; conducting technical project studies namely, technical research in the field of pharmaceutical studies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing science technology information; provision of medical research services; provision of scientific research information; provision of scientific information relating to chemicals; research and development in the field of medicine; research and development in the pharmaceutical and biotechnology fields; research and development of new products; research and development of vaccines and medicines; medical research laboratories; research of pharmaceuticals; research on the subject of pharmaceuticals; research relating to biotechnology, research relating to chemistry; research relating to pharmaceuticals; scientific research; scientific and industrial research in the field of mental health and wellness, mental health diseases and disorders, psychiatric diseases and disorders, mood disorders, depression, anxiety, stress, fatigue, sleeping disorders, eating disorders, pain, and inflammation; scientific research; scientific research in the field of pharmacy; scientific research relating to biology; technological consultation and research in the field of pharmaceutical studies; testing of pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 4, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 4, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 17, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 17, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 11, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 3, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 3, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 3, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 19, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 23, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 23, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 23, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 21, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 21, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 21, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 21, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 21, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 13, 2024RFNTREFUSAL PROCESSED BY IB—
Apr 24, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 24, 2024RFRRREFUSAL PROCESSED BY MPU—
Apr 7, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 6, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 13, 2024DOCKASSIGNED TO EXAMINER—
Oct 24, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 20, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 19, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance